Projected numbers of people with movement disorders in the years 2030 and 2050

Movement Disorders

Volumn 26, Issue 12, 2011, Pages 2286-2290

  Bach, Jan Philipp ^a   Ziegler, Uta ^b   Deuschl, Günther ^c   Dodel, Richard ^a   Doblhammer Reiter, Gabriele ^b  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Movement disorders; Neurodegeneration; Prevalence

Indexed keywords

AGE DISTRIBUTION; AGING; ARTICLE; ATAXIA; CANADA; CORTICOBASAL DEGENERATION; DIFFUSE LEWY BODY DISEASE; EPIDEMIOLOGICAL DATA; ESSENTIAL TREMOR; EUROPE; FOCAL DYSTONIA; GENERALIZED DYSTONIA; GILLES DE LA TOURETTE SYNDROME; HUMAN; HUNTINGTON CHOREA; MEDICAL LITERATURE; MOTOR DYSFUNCTION; PARKINSON DISEASE; PREVALENCE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; RESTLESS LEGS SYNDROME; SHY DRAGER SYNDROME; SYSTEMATIC REVIEW; UNITED STATES; WILSON DISEASE;

CANADA; EUROPE; FEMALE; HUMANS; LIFE EXPECTANCY; MALE; MOVEMENT DISORDERS; POPULATION DYNAMICS; PREDICTIVE VALUE OF TESTS; PREVALENCE; UNITED STATES;

EID: 80055097451     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23878     Document Type: Article

References (20)

1. Oeppen J, Vaupel JW. Demography. Broken limits to life expectancy. Science 2002; 296: 1029-1031.
2. Kaplan W Laing R. Priority medicines for europe and the world. World Health Organization. 2004. [Available at: ]. Accessed on February 2010.
3. WHO. Neurological disorders. Public health challenges. Geneva: World Health Organization; 2006.
4. Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J. Cost of disorders of the brain in Europe. Eur J Neurol 2005; 12(Suppl 1): 1-27.
5. Alves G, Forsaa EB, Pedersen KF, Dreetz Gjerstad M, Larsen JP. Epidemiology of Parkinson's disease. J Neurol 2008; 255(Suppl 5): 18-32.
6. Berger K, Kurth T. RLS epidemiology-frequencies, risk factors, and methods in population studies. Mov Disord 2007; 22(Suppl 18): S420-S423.
7. Harper PS. The epidemiology of Huntington's disease. Hum Genet 1992; 89: 365-376.
8. Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the "common" neurologic disorders? Neurology 2007; 68: 326-337.
9. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007; 68: 384-386.
10. Lugert P. Sample data from the statutory health insurance-foundation and structure of the data. Wiesbaden, Germany: Federal Statistical Office; 2007.
11. Ziegler U, Doblhammer, G. Projection of people with dementia in germany-projections of the number of people with dementia through 2047 In: Doblhammer G, ed. Ageing, Care Need, and Quality of Life-The Perspective of Care Givers and People in Need of Care. Wiesbaden, Germany: VS Verlag; 2010.
12. Doblhammer G, Ziegler U, Muth, E. Trends and patterns in life expectancy and health, and dementia projections for Germany until 2050. In: Kumbier E TS, Herpertz SC eds. Ethics and remembrence: the responsibility of psychiatry in the past and present. Lengerich, Germany: Pabst Science Publishers; 2009: 91-108.
13. Murray CJ, Lopez AD. Evidence-based health policy-lessons from the Global Burden of Disease Study. Science 1996; 274: 740-743.
14. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996; 276: 1253-1258.
15. Ziegler U, Doblhammer G. Prevalence and incidence of dementia in Germany - a study based on data from the public sickness funds in 2002. Das Gesundheitswesen 2009; 71: 281-290.
16. The Epidemiological Study of Dystonia in Europe (ESDE) Collaborative Group. A prevalence study of primary dystonia in eight European countries. J Neurol 2000; 247: 787-792.
17. Wenning GK, Kiechl S, Seppi K, et al. Prevalence of movement disorders in men and women aged 50-89 years (Bruneck Study cohort): a population-based study. Lancet Neurol 2005; 4: 815-820.
18. Dogu O, Sevim S, Camdeviren H, et al. Prevalence of essential tremor: door-to-door neurologic exams in Mersin Province, Turkey. Neurology 2003; 61: 1804-1806.
19. Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology 2000; 54: 1064-1068.
20. Chrysostome V, Tison F, Yekhlef F, Sourgen C, Baldi I, Dartigues JF. Epidemiology of multiple system atrophy: a prevalence and pilot risk factor study in Aquitaine, France. Neuroepidemiology 2004; 23: 201-208.